1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylicacid CAS:849217-48-7
Catalog Number | XD96276 |
Product Name | 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylicacid |
CAS | 849217-48-7 |
Molecular Formula | C11H10FNO3 |
Molecular Weight | 223.2 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid is a chemical compound with potential therapeutic effects in the field of medicinal chemistry. It falls under the category of carbamate derivatives and exhibits interesting characteristics with regards to its pharmacological properties.One potential effect of 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid is its ability to act as an analgesic or pain-relieving agent. Studies have shown that certain carbamate derivatives exhibit analgesic effects by modulating the function of specific neurotransmitter receptors involved in pain perception. These compounds can interact with receptors such as the mu-opioid receptor or inhibit enzymes involved in pain signaling pathways. Although research specifically on 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid is limited, this compound may have the potential to possess similar analgesic properties.Another potential effect of this compound is its antibacterial activity. Certain carbamate derivatives have demonstrated antibacterial effects against a range of Gram-positive and Gram-negative bacteria. These compounds can disrupt essential cellular processes in bacteria, leading to their growth inhibition or cell death. 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid may possess similar antimicrobial properties, although further research is needed to confirm its specific antibacterial activity.Furthermore, carbamate derivatives have been investigated for their potential antiviral activity. These compounds can interfere with viral replication processes or inhibit specific viral enzymes, thus exhibiting antiviral effects. While the antiviral activity of 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid has not been extensively studied, it is possible that it may possess inhibitory effects against certain viruses.In addition to its potential therapeutic effects, it is important to note that the synthesis, formulation, and delivery of 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid may also have an impact on its overall pharmaceutical effect. Factors such as its solubility, stability, and bioavailability can affect its efficacy and pharmacokinetics.It is worth mentioning that while the potential effects mentioned above are based on the general properties of carbamate derivatives, specific studies on 1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxylic acid are limited. Further research and evaluation are needed to fully understand its pharmacological effects, safety profile, and potential applications in various therapeutic areas.